Veracyte Inc (VCYT)
Healthcare
Diagnostics & Research
44.90 $
-3.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 150 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90 | 98 | 97 | 114 | 116 | 119 | 114 | 130 | 132 | 141 | 139 | 150 | 562 | |
| 28 | 29 | 34 | 37 | 37 | 40 | 35 | 40 | 41 | 36 | 38 | 41 | 156 | |
| 62 | 69 | 62 | 78 | 79 | 79 | 80 | 90 | 91 | 105 | 101 | 109 | 406 | |
| 13 | 19 | 16 | 16 | 18 | 19 | 18 | 16 | 16 | 21 | 27 | 29 | 93 | |
| 16 | 41 | 43 | 47 | 40 | 47 | 52 | 14 | 43 | 1.4 | 24 | 27 | 96 | |
| 94 | 104 | 67 | 73 | 67 | 75 | 77 | 95 | 68 | 79 | 77 | 85 | 309 | |
| -32 | -36 | -4.7 | 4.6 | 12 | 4.2 | 2.9 | -5.3 | 23 | 26 | 24 | 23 | 95 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| -30 | -30 | -1.9 | 7.4 | 17 | 3.4 | 7.4 | 1.3 | 19 | 41 | 30 | 27 | 116 | |
| -0.2 | -2.2 | 0.0 | 1.6 | 1.7 | -1.7 | 0.4 | 2.2 | -0.2 | -0.5 | 1.3 | 1.0 | 1.5 | |
| -30 | -28 | -1.9 | 5.7 | 15 | 5.1 | 7.0 | -1.0 | 19 | 41 | 29 | 25 | 114 | |
| -22 | -24 | 1.9 | 13 | 23 | 9.7 | 6.5 | 6.7 | 24 | 46 | 35 | 27 | 133 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.